Immediate adverse events following immunization (AEFI) in drive-through COVID-19 vaccination campaign in Yogyakarta, Indonesia: A cross-sectional study DOI Open Access

Lukman Ade Chandra,

Hera Nirwati, Dhite Bayu Nugroho

et al.

The Indian Journal of Medical Research, Journal Year: 2024, Volume and Issue: 160, P. 362 - 370

Published: Nov. 27, 2024

Background & objectives The COVID-19 pandemic has led to unprecedented global immunization efforts, with drive-through vaccination campaigns established expedite and ensure safe coverage. However, research on immediate adverse events following (AEFI) in these settings is limited. This study aims evaluate the frequency characteristics of AEFI during Yogyakarta, Indonesia, using Sinovac/CoronaVac vaccine Methods cross-sectional utilized secondary data from local registry managed by Faculty Medicine, Public Health, Nursing, Universitas Gadjah Mada, July 27 September 6, 2021. Participants included individuals aged over 11 yr without underlying medical conditions such as diabetes, hypertension, cancer, or asthma. Key recorded were age, gender, AEFI. Results Out 27,459 registrants, only 20,817 eligible received a dose. median participant age was 20 (IQR 10); 47 per cent male (9,712) 53 female (11,105). highest day 2021, 3,883 doses (18%). Among 79 participants who experienced [0.38%; 95% Confidence Interval (CI): 0.30-0.47], 19 8); 41 (34) 59 (48). Systemic (92%) more common than (6.3%), dizziness (77.2%) being most prevalent. Interpretation conclusions findings this suggest that occurred rarely setting, indicating method appears efficient for vaccinations, particularly context Most mild, underscoring importance preparedness close monitoring campaign sites patient safety enhance confidence.

Language: Английский

Adverse events among early caregivers' COVID-19 vaccination correlated inversely with intention to vaccinate their children DOI
Ran D. Goldman, Rebecca Hart, Jeffrey N. Bone

et al.

Vaccine, Journal Year: 2025, Volume and Issue: 55, P. 127001 - 127001

Published: March 23, 2025

Language: Английский

Citations

0
Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines DOI Creative Commons
Brenda L. Coleman, Iris Gutmanis, Susan J. Bondy

et al.

Vaccine, Journal Year: 2024, Volume and Issue: 42(24), P. 126271 - 126271

Published: Sept. 2, 2024

Background: The demand for COVID-19 vaccines has diminished as the pandemic lingers. Understanding vaccine hesitancy among essential workers is important in reducing impact of future pandemics by providing effective immunization programs delivered expeditiously. Method: Two surveys exploring acceptance 2021 and 2022 were conducted cohorts health care providers (HCP) education participating prospective studies illnesses uptake. Demographic factors opinions about (monovalent bivalent) public measures collected these self-reported surveys. Modified multivariable Poisson regression was used to determine associated with hesitancy. Results: In 2021, 3 % 2061 HCP 6 3417 reported (p < 0.001). December 2022, 21 868 24 1457 being hesitant receive a bivalent = 0.09). Hesitance be vaccinated monovalent earlier date survey completion, later receipt first dose, no influenza vaccination, less worry becoming ill COVID-19. Factors hesitance that common both two or fewer previous doses lower certainty safe effective. Conclusion: Education somewhat more likely than report but reasons similar. Hesitancy non-receipt (i.e., behaviour), concern infected SARS-CoV-2, concerns safety effectiveness cohorts. Maintaining inter-pandemic trust vaccines, ensuring rapid data generation during regarding effectiveness, transparent communication are all needed support vaccination programs.

Language: Английский

Citations

3
Immediate adverse events following immunization (AEFI) in drive-through COVID-19 vaccination campaign in Yogyakarta, Indonesia: A cross-sectional study DOI Open Access

Lukman Ade Chandra,

Hera Nirwati, Dhite Bayu Nugroho

et al.

The Indian Journal of Medical Research, Journal Year: 2024, Volume and Issue: 160, P. 362 - 370

Published: Nov. 27, 2024

Background & objectives The COVID-19 pandemic has led to unprecedented global immunization efforts, with drive-through vaccination campaigns established expedite and ensure safe coverage. However, research on immediate adverse events following (AEFI) in these settings is limited. This study aims evaluate the frequency characteristics of AEFI during Yogyakarta, Indonesia, using Sinovac/CoronaVac vaccine Methods cross-sectional utilized secondary data from local registry managed by Faculty Medicine, Public Health, Nursing, Universitas Gadjah Mada, July 27 September 6, 2021. Participants included individuals aged over 11 yr without underlying medical conditions such as diabetes, hypertension, cancer, or asthma. Key recorded were age, gender, AEFI. Results Out 27,459 registrants, only 20,817 eligible received a dose. median participant age was 20 (IQR 10); 47 per cent male (9,712) 53 female (11,105). highest day 2021, 3,883 doses (18%). Among 79 participants who experienced [0.38%; 95% Confidence Interval (CI): 0.30-0.47], 19 8); 41 (34) 59 (48). Systemic (92%) more common than (6.3%), dizziness (77.2%) being most prevalent. Interpretation conclusions findings this suggest that occurred rarely setting, indicating method appears efficient for vaccinations, particularly context Most mild, underscoring importance preparedness close monitoring campaign sites patient safety enhance confidence.

Language: Английский

Citations

0